IFNAR1 and neoplasm: Consistent with our hypothesis, the therapeutic effect of IFN-α4 was markedly reduced in IFNAR1−/− mice, implying that JAK–STAT signaling in tumor and non-tumor cells is important for the anti-tumor effects of IFN-α4 (Figure 6C).